Survey Results -

Life Sciences and Technology IPOs Stay Strong in Second Half Despite Bumps -

U.S. initial public offerings notched another robust year in 2019 despite bouts of volatility, a number of high-profile technology IPOs that struggled, and a slight drop in deal volume. A total of 108 companies went public in 2019, down from 112 in 2018—which was a particularly strong year for public markets. In particular, the second half of 2019 saw 49 life sciences and technology IPOs, down from the 59 in the first half of 2019.

By the Numbers -

In the second half of 2019, 49 life sciences and technology companies made their debut on the public markets, down from 59 in the first half of the year, continuing a trend of relative stability. Technology and life sciences offerings represented a bright spot in the market; 23 technology companies went public (down from 25 in the first half) and 26 life sciences companies completed offerings (down from 34 in the first half).